Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

China eases visa rules in Philippines for recipients of its vaccines

Published 03/15/2021, 06:48 PM
Updated 03/15/2021, 06:50 PM
© Reuters.
SVA
-

MANILA, March 15 (Reuters) - China's embassy in the
Philippines said on Monday it would simplify visa applications
for anyone in the country who has been inoculated with
Chinese-made COVID-19 vaccines to allow regular travel to
resume.
China will return to its pre-pandemic visa application
requirements for those fully vaccinated with its home-grown
vaccines, according to a statement by its embassy in Manila,
which is among the first to announce the policy.
The Philippines kicked off its vaccination drive among
health workers on March 1, using some of the 600,000 doses of
Sinovac Biotech SVA.O vaccine, CoronaVac, which were donated
by the Chinese government.
It has purchased a further 25 million doses of CoronaVac to
be delivered later. It is one of three coronavirus vaccines
granted emergency use approval by Philippine regulators.
The Philippines has also been discussing a vaccine supply
deal with China's Sinopharm, which has also applied for
emergency use authorisation.
China on March 13 announced streamlined visa procedures for
foreigners in Hong Kong "in view of resuming people-to-people
exchanges between China and other countries in an orderly
manner". Its embassy in Manila did not say why the simplified
procedures were not extended to those receiving other
coronavirus vaccines.
It said it would work with Philippine authorities to create
a mechanism to ensure vaccination certificates were issued to
facilitate travel.
China has engaged in vaccine diplomacy to boost its standing
in Asia and around the world, including offering Chinese-made
vaccine doses to participants at this year's Tokyo Olympics and
the Beijing 2022 Winter Games.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.